Atlantic Private Wealth’s Sarepta Therapeutics SRPT Stock Holding History

Atlantic Private Wealth’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$135K	Hold	7,500	–	–	0.08%	71
2026 Q1	$163K	Hold	7,500	–	–	0.11%	70
2025 Q4	$161K	Sell	7,500 -150	-2%	-$3.16K	0.1%	67
2025 Q3	$147K	Buy	7,650 +150	+2%	+$2.67K	0.1%	60
2025 Q2	$128K	Hold	7,500	–	–	0.09%	63
2025 Q1	$479K	Hold	7,500	–	–	0.35%	36
2024 Q4	$912K	Hold	7,500	–	–	0.69%	20
2024 Q3	$937K	Hold	7,500	–	–	0.71%	20
2024 Q2	$1.19M	Hold	7,500	–	–	0.97%	18
2024 Q1	$971K	Hold	7,500	–	–	0.81%	18
2023 Q4	$723K	Hold	7,500	–	–	0.65%	21
2023 Q3	$909K	Hold	7,500	–	–	0.92%	15
2023 Q2	$859K	Sell	7,500 -2,500	-25%	-$322K	0.87%	15
2023 Q1	$1.38M	Sell	10,000 -2,000	-17%	-$259K	1.45%	13
2022 Q4	$1.55M	Hold	12,000	–	–	1.67%	14
2022 Q3	$1.33M	Hold	12,000	–	–	1.49%	13
2022 Q2	$900K	Hold	12,000	–	–	0.92%	14
2022 Q1	$937K	Hold	12,000	–	–	0.89%	14
2021 Q4	$1.08M	Buy	+12,000	New	+$1.03M	0.95%	15

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Atlantic Private Wealth's SRPT Position: Q2 2026 in Review

Atlantic Private Wealth held its Sarepta Therapeutics (SRPT) position steady in Q2 2026 at 7,500 shares worth $135K. The position accounts for 0.08% of the portfolio, ranked #71.

Atlantic Private Wealth first reported a position in SRPT in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.55M in Q4 2022. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

Atlantic Private Wealth held 7,500 shares of Sarepta Therapeutics worth $135K as of Q2 2026.
Atlantic Private Wealth left its Sarepta Therapeutics share count unchanged in Q2 2026.
Sarepta Therapeutics made up 0.08% of Atlantic Private Wealth's portfolio in Q2 2026, its #71 holding.
Atlantic Private Wealth first reported a position in Sarepta Therapeutics in Q4 2021 and has held it in 19 quarters since.
Atlantic Private Wealth's Sarepta Therapeutics position peaked at $1.55M in Q4 2022.
323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Atlantic Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.